Skip to main content

Table 2 Clinicopathological characteristics in the SS, NASH, HCC with NAFLD, and virus-related HCC groups

From: Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study

 

SS (n = 40)

NASH (n = 40)

HCC with NAFLD (n = 55)

Virus-related HCC (n = 35)

Gender (male)

18 (45.0%)

23 (57.5%)

43 (75.7%) * **

24 (68.6%)

Age

43 (21–67)

44 (15–76)

73 (56–90) * **

68(41–80) ***

Obesity

9 (22.5%)

26 (65.0%) *

25 (45.5%) *

10 (28.6%)

Diabetes

1 (2.5%)

5 (12.5%)

31 (56.4%) * **

7 (20.0%) ***

Hypertension

3 (7.5%)

8 (20.0%)

23 (41.8%) * **

14 (40.0%)

Child-Pugh score

5.0 (±0.1)

5.1 (±0.1) *

5.4 (±0.2) * **

5.4 (±0.2)

Fibrosis a (F3, 4)

0 (0%)

5 (12.5%) *

19 (35.9%) * **

25 (73.5%) ***

Stage b (III, IV)

 

22 (40.0%)

12 (34.3%)

Tumor size

 

5.3 (±0.5)

3.2 (±0.5) ***

  1. Obesity was defined as a body mass index > 25
  2. Data are expressed as n (%) or the mean ± standard deviation. Age is median (range)
  3. * P <  0.05 compared with the SS group
  4. ** P <  0.05 compared with the NASH group
  5. *** P <  0.05 compared with the NAFLD with HCC group
  6. a Liver fibrosis was classified according to the METAVIR scoring system [15]
  7. b Stages were categorized according to the Japanese tumor-node-metastasis staging system [16]